Detalhe da pesquisa
1.
Multifunctional Natural Killer Cell Engagers Targeting NKp46 Trigger Protective Tumor Immunity.
Cell
; 177(7): 1701-1713.e16, 2019 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31155232
2.
Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells.
Cell
; 175(7): 1731-1743.e13, 2018 12 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-30503213
3.
Innate Immune Landscape in Early Lung Adenocarcinoma by Paired Single-Cell Analyses.
Cell
; 169(4): 750-765.e17, 2017 05 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28475900
4.
Host-Protozoan Interactions Protect from Mucosal Infections through Activation of the Inflammasome.
Cell
; 167(2): 444-456.e14, 2016 Oct 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27716507
5.
Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis.
Nature
; 588(7836): 146-150, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32726800
6.
Expansion and Activation of CD103(+) Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition.
Immunity
; 44(4): 924-38, 2016 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-27096321
7.
Autologous T cell responses to primary human colorectal cancer spheroids are enhanced by ectonucleotidase inhibition.
Gut
; 72(4): 699-709, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35803702
8.
Neutralizing Anti-Granulocyte Macrophage-Colony Stimulating Factor Autoantibodies Recognize Post-Translational Glycosylations on Granulocyte Macrophage-Colony Stimulating Factor Years Before Diagnosis and Predict Complicated Crohn's Disease.
Gastroenterology
; 163(3): 659-670, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35623454
9.
Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer.
Nature
; 551(7681): 512-516, 2017 11 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-29132146
10.
A Frameshift in CSF2RB Predominant Among Ashkenazi Jews Increases Risk for Crohn's Disease and Reduces Monocyte Signaling via GM-CSF.
Gastroenterology
; 151(4): 710-723.e2, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27377463
11.
The non-small cell lung cancer immune contexture. A major determinant of tumor characteristics and patient outcome.
Am J Respir Crit Care Med
; 191(4): 377-90, 2015 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25369536
12.
Immune biomarkers are more accurate in prediction of survival in ulcerated than in non-ulcerated primary melanomas.
Cancer Immunol Immunother
; 64(9): 1193-203, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26076664
13.
Presence of B cells in tertiary lymphoid structures is associated with a protective immunity in patients with lung cancer.
Am J Respir Crit Care Med
; 189(7): 832-44, 2014 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24484236
14.
Germinal center-dependent and -independent immune responses of tumor-infiltrating B cells in human cancers.
Cell Mol Immunol
; 20(9): 1040-1050, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37419983
15.
Antitumor immunity induced by antibody-based natural killer cell engager therapeutics armed with not-alpha IL-2 variant.
Cell Rep Med
; 3(10): 100783, 2022 10 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36260981
16.
Targeting MICA/B with cytotoxic therapeutic antibodies leads to tumor control.
Open Res Eur
; 1: 107, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-35967081
17.
Multiplexed Immunohistochemical Consecutive Staining on Single Slide (MICSSS): Multiplexed Chromogenic IHC Assay for High-Dimensional Tissue Analysis.
Methods Mol Biol
; 2055: 497-519, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-31502167
18.
Host tissue determinants of tumour immunity.
Nat Rev Cancer
; 19(4): 215-227, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30867580
19.
DNA alteration-based classification of uveal melanoma gives better prognostic stratification than immune infiltration, which has a neutral effect in high-risk group.
Cancer Med
; 8(6): 3036-3046, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-31025552
20.
Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA/B and NKG2A targeting for cancer treatment.
J Immunother Cancer
; 7(1): 74, 2019 03 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30871626